HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insulin enhanced thrombin-activable fibrinolysis inhibitor expression through PI3 kinase/Akt pathway.

Abstract
Thrombin-activable fibrinolysis inhibitor (TAFI) is a key modulator of fibrinolysis. We have reported the elevated levels of plasma TAFI and their correlation with visceral fat area and insulin resistance in the patients with type 2 diabetes. Furthermore, the expression of TAFI was demonstrated in adipose tissues. Thus, we hypothesized that TAFI secreted from adipose tissues might be an important causative factor of hypofibrinolysis in patients with insulin resistance and that insulin was a modulator of the gene expression of TAFI. To evaluate this hypothesis, we examined the regulation of TAFI expression by insulin in adipocytes. TAFI mRNA was induced dose-dependently by insulin in 3T3-L1 adipocytes. PI3 kinase inhibitor wortmannin inhibited insulin-induced expression, but MEK1 inhibitor PD98059 had no effects. These data suggested that the gene expression of TAFI was regulated by PI3 kinase signaling pathway. Moreover, activated Akt induced the expression of TAFI mRNA to a similar extent by insulin in 3T3-L1 adipocytes expressing tamoxifen-regulatable Akt. In conclusion, TAFI was induced by insulin through PI3 kinase/Akt pathway in adipocytes. It is supposed that plasma TAFI levels are regulated at least in part by transcription levels in adipose tissues of patients with insulin resistance.
AuthorsYasuko Hori, Kaname Nakatani, Kohei Morioka, Akira Katsuki, Esteban C Gabazza, Yutaka Yano, Tsutomu Nobori, Yukihiko Adachi, Yasuhiro Sumida
JournalInternational journal of molecular medicine (Int J Mol Med) Vol. 15 Issue 2 Pg. 265-8 (Feb 2005) ISSN: 1107-3756 [Print] Greece
PMID15647842 (Publication Type: Journal Article)
Chemical References
  • Androstadienes
  • Flavonoids
  • Insulin
  • Proto-Oncogene Proteins
  • RNA, Messenger
  • Tamoxifen
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Carboxypeptidase B2
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Wortmannin
Topics
  • 3T3-L1 Cells
  • Adipocytes (metabolism)
  • Adipose Tissue (metabolism)
  • Androstadienes (pharmacology)
  • Animals
  • Carboxypeptidase B2 (metabolism)
  • Dose-Response Relationship, Drug
  • Fibroblasts (metabolism)
  • Flavonoids (pharmacology)
  • Insulin (metabolism)
  • Insulin Resistance
  • Mice
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphorylation
  • Protein Serine-Threonine Kinases (metabolism)
  • Proto-Oncogene Proteins (metabolism)
  • Proto-Oncogene Proteins c-akt
  • RNA, Messenger (metabolism)
  • Retroviridae (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction
  • Tamoxifen (pharmacology)
  • Transcription, Genetic
  • Wortmannin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: